Longliv Ventures

Corporate VC Active Herzliya, Israel Est. 2015
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
3
in our dataset
Rounds participated
5
Rounds led
1
Rounds' value
$134.8M
total disclosed, rounds participated
Stages
Seed, B Round, A Round, C Round

About

Longliv Ventures is the investment arm of Cheung Kong Hutchison Holdings Limited (CKHH), a renowned multinational conglomerate listed on the main board of the Hong Kong Stock Exchange. The core business areas of CKHH include ports and related services, retail, infrastructure, energy, and telecommunications. Longliv Ventures targets early-stage companies to identify and support consumer digital health solutions that will augment and eventually revolutionize the way people manage their health and wellness. The fund is focused on large-scale markets for specific products ready to commercialize in the short term.

Portfolio · 3

PregnanTech
Preterm Birth Prevention
1 round Latest: 2026-01
Sight Diagnostics
Advanced Blood Diagnostics Platform
2 rounds $98.8M committed Latest: 2020-07
DayTwo
Precision Nutrition for Metabolic Disease
Led ★ 2 rounds $36.0M committed Latest: 2019-10

Investment activity

Portfolio by sector

Health Tech & Life Sciences3
Business Software1

Q&A

What is Longliv Ventures' primary investment focus?
Longliv Ventures, the investment arm of Cheung Kong Hutchison Holdings Limited (CKHH), focuses on identifying and supporting consumer digital health solutions that aim to revolutionize health and wellness management. Their focus is on large-scale markets for products ready to commercialize in the short term.
What investment stages does Longliv Ventures typically target?
Longliv Ventures targets companies in Seed, A Round, B Round, and C Round investment stages.
Can you name some of Longliv Ventures' notable portfolio companies?
Longliv Ventures' portfolio includes ApoWiser, a digital pharmacist platform, and DayTwo, which focuses on precision nutrition for metabolic disease.
What is Longliv Ventures' sector concentration?
Longliv Ventures shows a strong concentration in Health Tech & Life Sciences, with 3 portfolio companies in this sector. They also have one portfolio company in Business Software.
Who is a key team member at Longliv Ventures?
Dan Eldar serves as the Executive Director at Longliv Ventures and is also a founder of the firm.
When was Longliv Ventures founded?
Longliv Ventures was founded in 2015.
What is the most recent portfolio company added by Longliv Ventures?
Longliv Ventures added ApoWiser to its portfolio in January 2026, which is developing a digital pharmacist platform for advice on OTC medications.
What was Longliv Ventures' most recent investment round?
Longliv Ventures participated in a Seed round for ApoWiser in January 2026, which raised $1.5M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)